Allgens Medical Technology Co. Ltd.
- Jurisdiction
China - ISIN
CNE1000051W7 (688613.SS )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
4
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
1
/ 7
Profile
Allgens Medical Technology CO., LTD., a medical device company, develops and manufactures platforms of biomimetic synthetic bone grafts for use in regions of compromised cancellous and cortical bone worldwide. Read full profile
Fundamentals
- Net revenue
€24.49M - Gross margin
64.4% - EBIT
-€848.67K - EBIT margin
-3.5% - Net income
-€1.65M - Net margin
-6.8%
Statement period: - (published )
Stock price
Dividends
- Last dividend amount
-
CN¥0.06 - Ex date
-
- Payment date
-
Analyst ratings
No analyst ratings available
Insider Transactions
No insider transactions in the last 90 days. View older insider transactions